NCT04244591View on ClinicalTrials.gov

Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 26, 2020

Primary Completion Date

April 13, 2020

Study Completion Date

April 13, 2020

Conditions
COVID-19 Infections
Interventions
DRUG

methylprednisolone therapy

Methylprednisolone 40 mg q12h for 5 days

OTHER

Standard care

Standard care

Trial Locations (1)

010

Medical ICU,Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Zhongda Hospital

OTHER

collaborator

Zhongnan Hospital

OTHER

collaborator

Renmin Hospital of Wuhan University

OTHER

lead

Peking Union Medical College Hospital

OTHER

NCT04244591 - Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure | Biotech Hunter | Biotech Hunter